Nasdaq:US$18.25 (+1.31) | HKEX:HK$28.35 (+1.45) | AIM:£2.90 (+0.14)
搜索結果
上一篇文章   |   下一篇文章
公告及新聞稿, 其他業務 | 2014-04-17

Chi-Med and Sinopharm complete regulatory approval for the establishment of new China drug distribution and marketing Joint Venture